author-photo

Hellen Gelband

Center for Disease Dynamics, Economics & Policy

40

Papers

852

Citations

Citation Trend

Filter By

Papers (25) Sort By

Journal Conference Others

The economic case for investing in cancer control

2018 The Lancet Global Health
Show All
- Source
- Cite
- Save
Citations (2)
Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness

2017 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (52)
Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition

2016 The Lancet
Show All
- Source
- Cite
- Save
Citations (110)
Tackling antimicrobial resistance at global and local scales

2015 Trends in Microbiology
- Hellen Gelband
- Ramanan Laxminarayan
Show All
- Source
- Cite
- Save
Citations (50)
Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies

2014 BMJ Open
Show All
- Source
- Cite
- Save
Citations (5)
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission

2014 Cochrane Database of Systematic Reviews
Show All
- Source
- Cite
- Save
Citations (15)
Global survey of polymyxin use: A call for international guidelines §

2013 Journal of global antimicrobial resistance
Show All
- Source
- Cite
- Save
Citations (35)
Albendazole for lymphatic filariasis (Review)

2009
Show All
- Source
- Cite
- Save
Citations (1)
BOX 2-3, Targeted Cancer Therapies

2007
Show All
- Source
- Cite
- Save
Citations (0)
The Cancer Burden in Low- and Middle-Income Countries and How It Is Measured

2007
Show All
- Source
- Cite
- Save
Citations (9)